Trials / Completed
CompletedNCT02812498
Teleconsultation in Type 1 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Niguarda Hospital · Academic / Other
- Sex
- All
- Age
- 5 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effects on glycemic control of Teleconsultation versus standard visit in outpatient clinic for patients affected by type 1 diabetes mellitus.
Detailed description
The growing incidence of diabetes and the need to contain health care costs empower the necessity to identify new models to cope with regular periodic follow up of patients affected by diabetes mellitus. Telemedicine offers an acknowledged instrument to provide clinical health care at a distance, increasing patient compliance and the achievement of therapeutical goals. This study wants to verify the feasibility and the efficacy of teleconsultation in patients with type 1 diabetes mellitus. In particular by a randomized controlled approach the effects on glycemic control of patients followed by teleconsultation or traditionally in standard visit in the outpatient clinic. The patients in the teleconsultation group will arrange their bookings on a website (http://www.telediabete-fid.it/) In this website they could also access to web educational courses (mainly nutrition, insulin management, glucose monitoring auto-control) or to nutritional and psychological counselling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Teleconsultation | The patients in the consultation group arranged their bookings on a website, where they could also access to web educational courses or to nutritional and psychological counselling |
| OTHER | Standard | Group of patients followed in a traditional way |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2018-07-01
- Completion
- 2018-09-01
- First posted
- 2016-06-24
- Last updated
- 2019-03-15
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT02812498. Inclusion in this directory is not an endorsement.